Fig. 3From: A double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patientsAssociations between the change of adipose tissue compartments and HbA1c after treatment. Subcutaneous AT in relation to HbA1c, n = 44 (a), visceral AT in relation to HbA1c, n = 44 (b), epicardial AT in relation to HbA1c, n = 38 (c), paracardial AT in relation to HbA1c, n = 39 (d), Hepatic TGC in relation to HbA1c, n = 44 (e) and myocardial TGC in relation to HbA1c, n = 43 (f). Regression lines are shown for placebo (open symbol) and liraglutide (closed symbol) combined. AT adipose tissue, TGC triglyceride contentBack to article page